Left Main Lithotripsy: 7 Best Proven Board Facts
Left main lithotripsy board revision: device comparison, trial tables, Shockwave C2+ IFU numbers, test inflation, EBU 3.5 guide choice and 5 exam MCQs.
Interventional cardiology from the cath lab — coronary angioplasty and stenting, antiplatelet strategy, complex and high-risk PCI, and how landmark trial evidence translates into everyday decisions. Written by Dr A M Thirugnanam, MD, MSICP, FSCAI, Senior Interventional Cardiologist. Start with DAPT duration after PCI. Related titles are collected under interventional cardiology books; trainees moving towards a fellowship should also see the Cardiology Mentorship Program and the full Cardiology Learning Center.
Interventional cardiology from the cath lab — coronary angioplasty and stenting, antiplatelet strategy, complex and high-risk PCI, and how landmark trial evidence translates into everyday decisions. Written by Dr A M Thirugnanam, MD, MSICP, FSCAI, Senior Interventional Cardiologist. Start with DAPT duration after PCI. Related titles are collected under interventional cardiology books; trainees moving towards a fellowship should also see the Cardiology Mentorship Program and the full Cardiology Learning Center.
Left main lithotripsy board revision: device comparison, trial tables, Shockwave C2+ IFU numbers, test inflation, EBU 3.5 guide choice and 5 exam MCQs.
High-yield board revision on transcatheter tricuspid valve intervention: TRILUMINATE, Tri.Fr, TRISCEND II, TRI-SCORE bands, the 2025 ESC/EACTS and 2020 ACC/AHA recommendations, examiner traps and five single-best-answer questions with worked explanations.
ARC definitions, timing bands, the mechanism table, imaging targets and eight practice MCQs with worked answers on acute stent thrombosis.
No-reflow is the moment every interventionalist dreads. Why flow stops when the artery is open, how to tell the mechanisms apart at the table, and what actually restores perfusion.
DAPT duration after stenting is a balance, not a fixed number. How ischaemic and bleeding risk pull against each other, and how current guidance frames the decision.